Neuronetics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Neuronetics, Inc. (STIM) had Stockholders' Equity Attributable to Noncontrolling Interest of $3.79 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $3.79M.
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $3.79M.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $3.86M.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $4.00M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $3.79M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $3.79M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $3.86M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $4.00M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $4.36M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $4.08M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $4.09M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$3.60M 8-K/A · filed 2025-02-06 |
| 2023-12-31 | -$2.91M 8-K/A · filed 2025-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |